FDA announcement generates news

News
10 new
results for multiple sclerosis
FDA warns against multiple sclerosis treatment
Los Angeles
Times

The experimental ‘liberation therapy,’ which involves widening veins in the
head and neck to alleviate MS symptoms, has caused death and has no
proven benefit, the agency says. By Ian Duncan, Los Angeles Times WASHINGTON
— An experimental treatment
See all stories on this topic »
FDA Issues Warning About Experimental MS
Therapy

ABC News
The US Food and Drug Administration issued a warning about the potential
risks of an experimental therapy used to treat a condition — chronic
cerebrospinal venous insufficiency, or CCSVI — often linked to multiple
sclerosis
. CCSVI is characterized by
See all stories on this topic »
FDA Warns of Multiple Sclerosis Treatment
Wall Street
Journal

By THOMAS M. BURTON The Food and Drug Administration on Thursday warned that
a controversial treatment for multiple sclerosis has been tied to
serious complications, including stroke and death. Known to some backers as
“liberation therapy,” the
See all stories on this topic »
Experimental Multiple Sclerosis Treatment Could
Be Dangerous And Even Deadly: FDA

Huffington
Post

By Anna Yukhananov WASHINGTON, May 10 (Reuters) – US drug regulators are
warning people with multiple sclerosis that an experimental treatment
that props open internal veins in the neck and chest can cause death or
serious injury.
See all stories on this topic »
FDA Issues Warning on Controversial MS Treatment
Philadelphia
Inquirer

THURSDAY, May 10 (HealthDay News) — Doctors and patients need to be aware of
the potential risk of injuries and death associated with an experimental
treatment for multiple sclerosis called liberation therapy, the US
Food and Drug Administration said
See all stories on this topic »
FDA warns MS patients about risky stent
treatment

msnbc.com
US drug regulators are warning people with multiple sclerosis to avoid
an experimental treatment that props open internal veins in the neck and
chest, because it can cause death or serious injury. Don’t miss these Health
stories ‘Stronger’: Patient’s
See all stories on this topic »
FDA Warns MS Patients Against Unproven Stent
Procedure

BusinessWeek
By Michelle Fay Cortez on May 10, 2012 The US Food and Drug Administration
warned doctors and patients against the use of an unproven procedure known as
“liberation therapy” that some physicians have touted as a treatment for multiple
sclerosis
.
See all stories on this topic »
FDA issues warning about controversial MS
treatment

OCRegister
By COURTNEY PERKES / THE ORANGE COUNTY REGISTER The Food and Drug
Administration on Thursday issued a safety alert about an experimental
treatment for multiple sclerosis a year after a Canadian woman died
from the procedure in Orange County.
See all stories on this topic »
FDA issues alert on potential dangers of unproven
treatment for multiple sclerosis

FDA.gov
Some researchers believe that CCSVI, which is characterized by a narrowing
(stenosis) of veins in the neck and chest, may cause multiple sclerosis
(MS) or may contribute to the progression of the disease by impairing
blood drainage from the brain and
See all stories on this topic »
FDA Warns on Controversial MS Therapy
MedPage Today
By John Gever, Senior Editor, MedPage Today WASHINGTON — The FDA has issued
an alert warning about risks, including death, associated with endovascular
treatments for multiple sclerosis based on the controversial theory
that the disease is caused or
See all stories on this topic »

Blogs
3 new
results for multiple sclerosis
FDA issues warning on controversial MS treatment
(HealthDay)
— Doctors and patients need to be aware of the potential risk of injuries
and death associated with an experimental treatment for multiple
sclerosis
called liberation therapy, the U.S. Food and Drug
Administration said in an alert
Medical Xpress – latest medical…
FDA Issues Warning on Controversial MS Treatment
– Drugs.com

Doctors
and patients need to be aware of the potential risk of injuries and death
associated with an experimental treatment for multiple sclerosis
called libera.
Drugs.com – Daily MedNews
NDA Accepted for BG-12 for Multiple Sclerosis
MPR

Biogen
Idec announced that the FDA has accepted for filing the company’s New Drug
Application (NDA) for BG-12 (dimethyl fumarate) for the treatment of multiple
sclerosis
(MS).
Latest articles from MPR
Web
2 new
results for multiple sclerosis
FDA warns MS patients about risky treatment –
Yahoo! News

From
Yahoo! News: WASHINGTON (Reuters) – U.S. drug regulators are warning people
with multiple sclerosis that an experimental treatment that props open

news.yahoo.com/fda-warns-ms-patients-risky-stent-treatment-…
Acupuncture & PEA for Multiple Sclerosis
Pain

Acupuncture
combined with PEA helps to control multiple sclerosis related pain.
www.healthcmi.com/…/540-acupunctureceuspeamultiplesclero…

4 thoughts on “FDA announcement generates news”

  1. Not a jot; once you put on a pair of blinkers you can't see the forest for the trees. I bet as the FDA is partially funded by Pharma they will soon be included in the conspiracy theory.

  2. I'm afraid you're right MD2. How many participants were enrolled before the trials were terminated? Given that their protocol wasn't even approved by an IRB (did they even have an IRB set up?), is it correct to surmise that had the trial continued, the participants' would have been treated no better than lab rats (that is they wouldn't have been to say that they truly were informed about the trial and consented to being a participant)? And why didn't the trial sponsor simply comply to the FDA's requests rather than terminate their trial?I find the situation really creepy and am amazed that anyone in this day and age, thought that they could get away with circumventing the law and violating the rights of the participants. Worse are the angry responses online to the FDA announcement by the "true believers", especially those from Canada. The FDA has the strict standards it does because of the thalidomide tragedy experienced there and abroad. Far from being a friend of "Big Pharma", the FDA stopped the practice of accepting anecdotal "evidence" given by doctors and patients and demanded that pharma companies back their claims with proper clinical trials. Despite its imperfections, I'm grateful that the FDA is looking out for us.

  3. The next step, which I hope will be soon, is to close down the clinics offering this procedure (for a big fat fee) around the world as has been done for the bogus stem cell quack clinics of a few years back.

Leave a Reply

%d bloggers like this: